Ennogen
Paul Tucker is currently serving as the Head of Quality at Ennogen. Prior to this role, Paul held various quality management positions at Church & Dwight Co., Inc., Aesica Pharmaceuticals Ltd, and CooperVision, where Paul was the Senior Quality Manager. Paul also previously worked as the Chemistry Laboratory Manager at Sauflon Pharmaceuticals. Paul holds a Bachelor's Degree with Distinction in Environmental Chemistry from the University of Hertfordshire.
Ennogen
Founded in 2011 by CEO John Ruprai, Ennogen is a privately owned British company offering a range of medicines, medical devices, unlicensed medicines, and OTC products. Since it was established, Ennogen has developed a differentiated portfolio of over 150 Market Authorisations, holds the ISO13485 accreditation and is the legal manufacturer and distributor of a range of medical devices. Our commercial coverage extends across the entire UK mainline and shortline wholesale channels, private and NHS hospitals, community and retail pharmacies and Clinical Commissioning Groups. Ennogen continues to establish itself as a leading choice for pharmacists and clinicians for numerous products. Our commitment is to provide quality and affordable pharmaceutical products to our local, national, and international clientele in an ethical, efficient and professional manner.